- Home
- LW vs JAZZ Comparison
LW vs JAZZ Comparison
Compare LW & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LW
- JAZZ
- Stock Information
- Founded
- LW 1950
- JAZZ 2003
- Country
- LW United States
- JAZZ Ireland
- Employees
- LW N/A
- JAZZ N/A
- Industry
- LW Packaged Foods
- JAZZ Biotechnology: Pharmaceutical Preparations
- Sector
- LW Consumer Staples
- JAZZ Health Care
- Exchange
- LW Nasdaq
- JAZZ Nasdaq
- Market Cap
- LW 9.0B
- JAZZ 8.2B
- IPO Year
- LW N/A
- JAZZ 2007
- Fundamental
- Price
- LW $62.96
- JAZZ $135.64
- Analyst Decision
- LW Buy
- JAZZ Strong Buy
- Analyst Count
- LW 10
- JAZZ 14
- Target Price
- LW $69.40
- JAZZ $179.43
- AVG Volume (30 Days)
- LW 1.9M
- JAZZ 657.4K
- Earning Date
- LW 12-18-2025
- JAZZ 11-05-2025
- Dividend Yield
- LW 2.34%
- JAZZ N/A
- EPS Growth
- LW N/A
- JAZZ N/A
- EPS
- LW 2.08
- JAZZ N/A
- Revenue
- LW $6,456,500,000.00
- JAZZ $4,086,695,000.00
- Revenue This Year
- LW $4.12
- JAZZ $5.75
- Revenue Next Year
- LW N/A
- JAZZ $6.09
- P/E Ratio
- LW $30.41
- JAZZ N/A
- Revenue Growth
- LW 0.00
- JAZZ 4.52
- 52 Week Low
- LW $47.87
- JAZZ $95.49
- 52 Week High
- LW $83.98
- JAZZ $148.06
- Technical
- Relative Strength Index (RSI)
- LW 51.09
- JAZZ 52.15
- Support Level
- LW $62.69
- JAZZ $133.45
- Resistance Level
- LW $67.07
- JAZZ $140.00
- Average True Range (ATR)
- LW 1.34
- JAZZ 3.15
- MACD
- LW -0.45
- JAZZ -0.53
- Stochastic Oscillator
- LW 9.86
- JAZZ 42.54
About LW Lamb Weston Holdings Inc.
Lamb Weston is North America's largest and the world's second-largest producer of branded and private-label frozen potato products, both by volume and value. The company's portfolio is anchored by french fries, but it also sells sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips. Roughly two thirds of revenue comes from its home market of North America, with none of the other 100 countries the company sells into representing a significant share. McDonald's is Lamb Weston's single-largest customer at 15% of fiscal 2025 sales, with no other company representing more than 10%. Lamb Weston became an independent company in 2016 when it was spun off from Conagra.
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.